Clinical Trial Update: Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 fatty acids for hyperactivity symptoms in autism spectrum disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorders
• Hyperactivity

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Autism Spectrum Disorders, Hyperactivity | Phase 2 | Status: COMPLETED | Results posted: 2014-06-16